- Home
- ATLO vs TLSI Comparison
ATLO vs TLSI Comparison
Compare ATLO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- TLSI
- Stock Information
- Founded
- ATLO 1903
- TLSI 2010
- Country
- ATLO United States
- TLSI United States
- Employees
- ATLO N/A
- TLSI N/A
- Industry
- ATLO Major Banks
- TLSI Medical Specialities
- Sector
- ATLO Finance
- TLSI Health Care
- Exchange
- ATLO Nasdaq
- TLSI Nasdaq
- Market Cap
- ATLO 158.4M
- TLSI 204.0M
- IPO Year
- ATLO N/A
- TLSI N/A
- Fundamental
- Price
- ATLO $18.16
- TLSI $5.11
- Analyst Decision
- ATLO
- TLSI Strong Buy
- Analyst Count
- ATLO 0
- TLSI 5
- Target Price
- ATLO N/A
- TLSI $10.90
- AVG Volume (30 Days)
- ATLO 16.2K
- TLSI 150.6K
- Earning Date
- ATLO 08-08-2025
- TLSI 08-13-2025
- Dividend Yield
- ATLO 4.49%
- TLSI N/A
- EPS Growth
- ATLO 14.69
- TLSI N/A
- EPS
- ATLO 1.27
- TLSI N/A
- Revenue
- ATLO $55,041,000.00
- TLSI $32,141,000.00
- Revenue This Year
- ATLO N/A
- TLSI $55.52
- Revenue Next Year
- ATLO N/A
- TLSI $54.76
- P/E Ratio
- ATLO $14.07
- TLSI N/A
- Revenue Growth
- ATLO 6.77
- TLSI 46.20
- 52 Week Low
- ATLO $15.69
- TLSI $3.50
- 52 Week High
- ATLO $22.03
- TLSI $6.04
- Technical
- Relative Strength Index (RSI)
- ATLO 54.10
- TLSI 52.80
- Support Level
- ATLO $17.19
- TLSI $5.18
- Resistance Level
- ATLO $17.67
- TLSI $5.50
- Average True Range (ATR)
- ATLO 0.37
- TLSI 0.33
- MACD
- ATLO 0.02
- TLSI -0.00
- Stochastic Oscillator
- ATLO 89.69
- TLSI 69.23
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.